FULLER & THALER ASSET MANAGEMENT, INC. - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$33,418,194
+2.5%
2,543,242
-1.7%
0.19%
+3.8%
Q2 2023$32,590,636
-3.3%
2,586,558
+0.1%
0.18%
-4.6%
Q1 2023$33,712,247
+72731.5%
2,583,314
-1.6%
0.19%
-34.0%
Q4 2022$46,288
-99.9%
2,624,051
-9.3%
0.29%
-7.3%
Q3 2022$44,060,000
+4.6%
2,892,942
+1.8%
0.32%
+9.3%
Q2 2022$42,137,000
-51.3%
2,841,368
-26.0%
0.29%
-43.5%
Q1 2022$86,510,000
+8.5%
3,841,491
-11.1%
0.51%
+10.8%
Q4 2021$79,700,000
+25.6%
4,319,757
-9.0%
0.46%
+13.2%
Q3 2021$63,467,000
-31.7%
4,746,967
-5.4%
0.41%
-32.2%
Q2 2021$92,928,000
+20.4%
5,020,395
-2.3%
0.60%
+11.3%
Q1 2021$77,170,000
+6.7%
5,139,537
+2.6%
0.54%
-19.0%
Q4 2020$72,314,000
+47.9%
5,007,871
-16.6%
0.67%
+8.1%
Q3 2020$48,897,000
+1.2%
6,007,004
-15.9%
0.62%
-2.4%
Q2 2020$48,336,000
-5.6%
7,139,707
-1.8%
0.63%
-26.5%
Q1 2020$51,209,000
-33.3%
7,273,953
-7.0%
0.86%
+0.8%
Q4 2019$76,731,000
-19.5%
7,817,746
-9.9%
0.86%
-24.1%
Q3 2019$95,260,000
-0.5%
8,675,749
+5.4%
1.13%
+1.2%
Q2 2019$95,735,000
+34.9%
8,231,709
+10.7%
1.12%
+24.2%
Q1 2019$70,954,000
+26.7%
7,437,549
+28.0%
0.90%
+11.3%
Q4 2018$56,020,000
-41.2%
5,811,190
-13.1%
0.81%
-18.1%
Q3 2018$95,260,000
+16.1%
6,684,904
-2.2%
0.98%
+11.0%
Q2 2018$82,040,000
+7.5%
6,836,652
+10.7%
0.89%
-0.8%
Q1 2018$76,305,000
+3.4%
6,178,529
+21.8%
0.89%
+0.7%
Q4 2017$73,803,000
+2.5%
5,072,348
+0.2%
0.89%
+0.8%
Q3 2017$72,033,000
+12.6%
5,062,035
+1.0%
0.88%
+5.1%
Q2 2017$63,956,000
+1.1%
5,012,212
+0.5%
0.84%
-2.9%
Q1 2017$63,253,000
+33.9%
4,988,377
+7.8%
0.86%
+21.2%
Q4 2016$47,247,000
-18.9%
4,627,481
+4.6%
0.71%
-26.0%
Q3 2016$58,286,000
+2.9%
4,425,699
-0.7%
0.96%
-0.8%
Q2 2016$56,618,000
-15.6%
4,458,105
-12.2%
0.97%
-25.5%
Q1 2016$67,071,000
+8.8%
5,077,304
+26.7%
1.30%
-1.2%
Q4 2015$61,629,000
+62.1%
4,007,060
+30.7%
1.32%
+34.1%
Q3 2015$38,022,000
+18.0%
3,066,275
+30.1%
0.98%
+7.9%
Q2 2015$32,231,000
+40.0%
2,356,062
+22.4%
0.91%
+23.9%
Q1 2015$23,019,0001,924,6690.74%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q3 2017
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders